First-Line Treatment for Iron Deficiency Anemia
The first-line treatment for iron deficiency anemia is oral iron supplementation, most commonly with ferrous sulfate 200 mg three times daily. 1
Oral Iron Therapy
- Oral iron supplementation is the simplest, least expensive, and most effective approach to correct anemia and replenish iron stores 1
- Ferrous sulfate 200 mg three times daily is the most commonly recommended formulation, though ferrous gluconate and ferrous fumarate are equally effective 1
- Treatment should continue for three months after correction of anemia to adequately replenish iron stores 1
- Expected response: Hemoglobin concentration should rise by approximately 2 g/dl after 3-4 weeks of treatment 1
- Alternative formulations may be used if the standard tablet form is not tolerated:
Monitoring and Follow-up
- Hemoglobin concentration and red cell indices should be monitored at regular intervals 1
- Recommended schedule: Every three months for one year, then after a further year 1
- Additional oral iron should be given if hemoglobin or MCV falls below normal 1
- Failure to respond to oral iron therapy may be due to:
- Poor compliance
- Misdiagnosis
- Continued blood loss
- Malabsorption 1
Special Considerations
Inflammatory Bowel Disease (IBD)
- For patients with IBD and iron deficiency anemia:
- Oral iron should be considered first-line for those with mild anemia, clinically inactive disease, and no previous intolerance to oral iron 1
- Intravenous iron should be considered first-line for patients with:
- Clinically active IBD
- Previous intolerance to oral iron
- Hemoglobin below 100 g/L
- Need for erythropoiesis-stimulating agents 1
When to Consider Parenteral Iron
- Parenteral iron should only be used when:
- Drawbacks of parenteral iron include:
Common Pitfalls and Caveats
- Excessive dosing: Recent evidence suggests that lower doses (100 mg daily or every other day) may be as effective as traditional higher doses while causing fewer side effects 3, 2
- Gastrointestinal side effects are common with oral iron and may reduce compliance 4
- Failure to treat the underlying cause: While supplementing iron, it's essential to identify and address the source of iron loss or poor absorption 1
- Inadequate duration of therapy: Treatment should continue for three months after normalization of hemoglobin to replenish iron stores 1
- Overlooking inflammation: In patients with inflammatory conditions, serum ferritin up to 100 μg/L may still be consistent with iron deficiency 1
By following these guidelines for oral iron supplementation as first-line therapy for iron deficiency anemia, with appropriate monitoring and consideration of special circumstances, most patients will achieve resolution of their anemia and replenishment of iron stores.